Literature DB >> 31129223

Comparison of Anterior Approach and Posterior Approach to Instrumented Interbody Fusion for Spondylolisthesis: A Meta-analysis.

Jae Young Cho1, Tae Sik Goh2, Seung Min Son3, Dong Suk Kim2, Jung Sub Lee4.   

Abstract

OBJECTIVE: To compare outcomes of instrumented interbody fusion by the anterior approach (anterior lumbar interbody fusion [ALIF] with posterior pedicle screw fixation [PPF] or lateral lumbar interbody fusion [XLIF] with PPF) or the posterior approach (transforaminal lumbar interbody fusion [TLIF] or posterior lumbar interbody fusion [PLIF]) for spondylolisthesis through meta-analysis.
METHODS: The MEDLINE via PubMed, Cochrane, Scopus, and Embase databases were searched for studies published between January 2010 and January 2019 evaluating outcomes including lumbar lordosis (LL), segmental lordosis (SL), slip rate, disc height (DH), back visual analogue scale (VAS), leg VAS, and Oswestry disability index (ODI) of ALIF with PPF or XLIF with PPF and TLIF or PLIF for spondylolisthesis. Two authors performed the data extraction independently. Any discrepancies were resolved by a consensus.
RESULTS: Eight comparative studies were identified. There was no significant difference between the anterior approach and the posterior approach for preoperative LL, SL, and DH. In addition, postoperative back and leg VAS, and ODI between the 2 groups were not different. However, the anterior approach was more effective for restoration of postoperative LL, SL, and DH than the posterior approach.
CONCLUSIONS: A literature review identified 8 comparative studies reporting outcomes of the anterior approach and the posterior approach in instrumented interbody fusion for spondylolisthesis. Despite heterogeneity, a limited meta-analysis showed that the postoperative restoration of LL, SL, and DH was better in the anterior approach group. Further large multicenter studies would be necessary to substantiate our results.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anterior lumbar interbody fusion; Lateral lumbar interbody fusion; Posterior lumbar interbody fusion; Spodylolisthesis; Transforaminal lumbar interbody fusion

Mesh:

Year:  2019        PMID: 31129223     DOI: 10.1016/j.wneu.2019.05.130

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

1.  Circumferential Fusion Employing Transforaminal vs. Direct Lateral Lumbar Interbody Fusion-A Potential Impact on Implants Stability.

Authors:  Andrey Bokov; Svetlana Kalinina; Andrei Leontev; Sergey Mlyavykh
Journal:  Front Surg       Date:  2022-05-16

2.  Retrospective radiographic analysis of anterior lumbar fusion for high grade lumbar spondylolisthesis.

Authors:  Maziyar A Kalani; Pelagia Kouloumberis; Alexandra E Richards; Mark K Lyons; Victor J Davila; Matthew T Neal
Journal:  J Spine Surg       Date:  2020-12

3.  Oblique Lateral Interbody Fusion versus Transforaminal Lumbar Interbody Fusion in Degenerative Lumbar Spondylolisthesis: A Single-Center Retrospective Comparative Study.

Authors:  Xing Du; Yuxiao She; Yunsheng Ou; Yong Zhu; Wei Luo; Dianming Jiang
Journal:  Biomed Res Int       Date:  2021-03-20       Impact factor: 3.411

4.  Effects and Safety of Lumbar Fusion Techniques in Lumbar Spondylolisthesis: A Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Yi-No Kang; Yu-Wan Ho; William Chu; Wen-Shiang Chou; Shih-Hao Cheng
Journal:  Global Spine J       Date:  2021-03-23

5.  Lumbar Interbody Fusion: Techniques, Pearls and Pitfalls.

Authors:  Young-Hoon Kim; Kee-Yong Ha; Kee-Won Rhyu; Hyung-Youl Park; Chang-Hee Cho; Hun-Chul Kim; Hyo-Jin Lee; Sang-Il Kim
Journal:  Asian Spine J       Date:  2020-10-14

6.  A retrospective controlled study protocol of transforaminal lumbar interbody fusion compared with posterior lumbar interbody fusion for spondylolisthesis.

Authors:  Ping Yi; Xiangsheng Tang; Feng Yang; Mingsheng Tan
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.